EKSO BIONICS HOLDINGS, INC. (EKSO) - Dilution Analysis

8-K filing: The Company entered into a securities purchase agreement to sell 1,311,407 shares of Common Stock to Applied Parent at a price of $12.01 per share for gross proceeds of approximately $15.75 million. ($15.75M proceeds)

10-Q filing | 3.6M shares outstanding

8-K filing: Ekso Bionics Holdings, Inc. completed a private placement issuing Series B Convertible Preferred Stock and warrants, with net proceeds of approximately $5.3 million, intended for working capital and general corporate purposes. ($5.85M proceeds)

10-Q filing | 2.6M shares outstanding

10-Q filing | 2.6M shares outstanding

8-K filing: Stock split 1-for-15 | Outstanding: 2,400,000 → 2,400,000

8-K filing: Stock split 1-for-15 | Outstanding: 25,393,000 → 2,400,000

10-Q filing | 25.4M shares outstanding

S-3 filing: This S-3 filing registers the resale of up to 10,500,000 shares of common stock issuable upon exercise of a common stock purchase warrant by a selling stockholder.

8-K filing: Ekso Bionics Holdings, Inc. entered into a warrant inducement agreement with an existing holder, who agreed to exercise warrants to purchase 9,800,000 shares of common stock at $0.4239 per share. ($4.15M proceeds)

10-K filing | 20.2M shares outstanding

10-Q filing | 20.3M shares outstanding

8-K filing: Ekso Bionics Holdings, Inc. closed a public offering on September 3, 2024, issuing and selling 3,100,000 shares of common stock, Series A Warrants to purchase 6,000,000 shares, Series B Warrants to purchase 6,000,000 shares, and Pre-Funded Warrants to purchase 2,900,000 shares, resulting in net proceeds of approximately $5.1 million.

S-1/A filing: S-1/A filing on 2024-08-28 for an offering of 5,530,973 Units, Each Unit Consisting of One Share of Common Stock (or One Pre-Funded Warrant to Purchase One Share of Common Stock in Lieu Thereof), One Series A Warrant to Purchase One Share of Common Stock and One Series B Warrant to Purchase One Share of Common Stock and 16,592,919 Shares of Common Stock Issuable Upon the Exercise of the Pre-Funded Warrants, Series A Warrants and Series B Warrants

10-Q filing | 18.2M shares outstanding

S-1 filing: S-1 filing for shares of common stock and pre-funded warrants to purchase shares of common stock.

10-Q filing | 17.4M shares outstanding

10-K filing | 13.9M shares outstanding

8-K filing: Ekso Bionics Holdings, Inc. completed a registered direct offering on January 16, 2024, selling 2,967,742 shares of common stock at $1.55 per share, resulting in net proceeds of approximately $4.0 million for general corporate purposes.

10-Q filing | 14.1M shares outstanding

10-Q filing | 13.6M shares outstanding

S-3 filing: Ekso Bionics Holdings, Inc. may offer and sell common stock, preferred stock, debt securities, warrants, subscription rights and units in one or more offerings up to an aggregate offering price of $75,000,000.

8-K filing: Ekso Bionics Holdings, Inc. amended its At the Market Offering Agreement with H.C. Wainwright & Co., LLC, removing the $6.75 per share floor sales price and reported that it has issued and sold 77,594 shares at an average price of $10.72 for proceeds of $791,217. ($0.79M proceeds)

10-Q filing | 13.3M shares outstanding

10-K filing | 13.0M shares outstanding

10-Q filing | 13.1M shares outstanding

10-Q filing | 12.9M shares outstanding

10-Q filing | 12.7M shares outstanding

10-K filing | 12.3M shares outstanding

10-Q filing | 12.7M shares outstanding

10-Q filing | 12.7M shares outstanding

10-Q filing | 12.7M shares outstanding

10-K filing | 12.6M shares outstanding

8-K filing: Ekso Bionics Holdings, Inc. closed a public offering of 3,902,440 shares of common stock at $10.25 per share on February 11, 2021, and issued warrants to purchase 273,170 shares of common stock to Wainwright's designees. ($40.0M proceeds)

10-Q filing | 8.4M shares outstanding

10-Q filing | 8.3M shares outstanding

8-K filing: Ekso Bionics Holdings, Inc. disclosed that parties designated by JV Partners purchased an aggregate of 204,499 shares of the Company's common stock at a price per share equal to $24.45, for aggregate proceeds to the Company of $5.0 million. ($5.0M proceeds)

S-1 filing: This S-1 filing registers the resale of up to 873,852 shares of common stock issuable upon the exercise of warrants issued on June 10, 2020. The company will not receive proceeds from the sale of these shares by the selling stockholders, but will receive proceeds from the exercise of the warrants.

8-K filing: Ekso Bionics Holdings, Inc. completed a registered direct offering and concurrent private placement on June 10, 2020, issuing 1,747,704 shares of common stock at $4.5145 per share and warrants to purchase up to 873,852 shares, raising approximately $7.89 million in gross proceeds. ($7.89M proceeds)

10-Q filing | 5.8M shares outstanding

8-K filing: Stock split 1-for-15 | Outstanding: 87,050,070 → 5,803,338

10-K filing | 87.1M shares outstanding